.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Fuji
Chinese Patent Office
Cantor Fitzgerald
Boehringer Ingelheim
Novartis
US Army
Teva
McKinsey

Generated: December 12, 2017

DrugPatentWatch Database Preview

Spironolactone - Generic Drug Details

« Back to Dashboard

What are the generic sources for spironolactone and what is the scope of spironolactone freedom to operate?

Spironolactone
is the generic ingredient in three branded drugs marketed by Cmp Dev Llc, Gd Searle Llc, Accord Hlthcare, Actavis Elizabeth, Amneal Pharms, Ascot, Ivax Pharms, Jubilant Generics, Lederle, Mutual Pharm, Mylan, Orion Corp Orion, Purepac Pharm, Sandoz, Sun Pharm Industries, Superpharm, Upsher Smith, Vangard, Vintage, Warner Chilcott, and Watson Labs, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Spironolactone has one patent family member in one country.

There are fifteen drug master file entries for spironolactone. Forty-three suppliers are listed for this compound.

Pharmacology for spironolactone

Medical Subject Heading (MeSH) Categories for spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Accord HlthcareSPIRONOLACTONEspironolactoneTABLET;ORAL203512-002Sep 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanSPIRONOLACTONEspironolactoneTABLET;ORAL040424-002Aug 20, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SuperpharmSPIRONOLACTONEspironolactoneTABLET;ORAL089364-001Nov 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcALDACTONEspironolactoneTABLET;ORAL012151-009Dec 30, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Purepac PharmSPIRONOLACTONEspironolactoneTABLET;ORAL087998-001Oct 14, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethSPIRONOLACTONEspironolactoneTABLET;ORAL040353-001Jul 29, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orion Corp OrionSPIRONOLACTONEspironolactoneTABLET;ORAL202187-003Mar 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcALDACTONEspironolactoneTABLET;ORAL012151-008Dec 30, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Purepac PharmSPIRONOLACTONEspironolactoneTABLET;ORAL088053-001Aug 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesSPIRONOLACTONEspironolactoneTABLET;ORAL089424-002Aug 11, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: spironolactone

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2017075463► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Citi
Johnson and Johnson
Fish and Richardson
UBS
US Department of Justice
AstraZeneca
McKesson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot